Abeona Therapeutics Inc (NASDAQ: ABEO) established initial surge of 18.47% at $4.94, as the Stock market unbolted on Wednesday, before settling in for the price of $4.17 at the close. Taking a more long-term approach, ABEO posted a 52-week range of $3.93-$7.54.
It was noted that the giant of the Healthcare sector posted annual sales growth of 47.21% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 47.21%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 180.11%. This publicly-traded company’s shares outstanding now amounts to $51.25 million, simultaneously with a float of $45.68 million. The organization now has a market capitalization sitting at $253.31 million. At the time of writing, stock’s 50-day Moving Average stood at $5.43, while the 200-day Moving Average is $5.75.
Abeona Therapeutics Inc (ABEO) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Abeona Therapeutics Inc industry. Abeona Therapeutics Inc’s current insider ownership accounts for 10.92%, in contrast to 64.88% institutional ownership. According to the most recent insider trade that took place on Oct 16 ’25, this organization’s Chief Executive Officer sold 249 shares at the rate of 5.49, making the entire transaction reach 1,366 in total value, affecting insider ownership by 1,189,818.
Abeona Therapeutics Inc (ABEO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
Abeona Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 180.11% and is forecasted to reach 0.04 in the upcoming year.
Abeona Therapeutics Inc (NASDAQ: ABEO) Trading Performance Indicators
Let’s observe the current performance indicators for Abeona Therapeutics Inc (ABEO). It’s Quick Ratio in the last reported quarter now stands at 6.65. Alongside those numbers, its PE Ratio stands at $7.83, and its Beta score is 1.13. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 633.29.
In the same vein, ABEO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.63, a figure that is expected to reach -0.24 in the next quarter, and analysts are predicting that it will be 0.04 at the market close of one year from today.
Technical Analysis of Abeona Therapeutics Inc (ABEO)
Now, what If we examine the latest scores posted by [Abeona Therapeutics Inc, ABEO]. During the last 5-days, its volume was better the volume of 1.13 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 29.04% While, its Average True Range was 55.64.
Raw Stochastic average of Abeona Therapeutics Inc (ABEO) in the period of the previous 100 days is set at 26.55%, which indicates a major fall in contrast to 58.57% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.31 that was higher than 0.28 volatility it exhibited in the past 100-days period.
